8-K
Current Report
Compass Therapeutics, Inc. Filed Acc 0001564590-21-027411
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading cmpx-8k_20210512.htm…